Medicare Part D Overcharged: Insulin, Vaccine, or OOP Cap

What This Means

Medicare has statutory cost-sharing limits for covered insulin, certain adult vaccines and annual Part D drug costs. Before requesting a refund, check whether the prescription was covered, which Medicare benefit paid it, the quantity or days supplied, and which limit applied on that date.

There are three price caps you should know about, all created by the Inflation Reduction Act:

First, covered Part D insulin has a product-specific monthly limit. In 2026, a one-month supply of each covered insulin product costs no more than the lowest of $35, 25% of the plan’s negotiated price, or 25% of the maximum fair price, if applicable. The Part D deductible does not apply. That means a charge below $35 can still be too high. Ask the plan to confirm the correct amount for your product and days supplied. This rule covers Part D plans, including Medicare Advantage plans with drug coverage; it does not itself make a non-covered insulin covered. CMS explains the 2026 calculation. Insulin used in a Part B-covered pump has a separate monthly limit of $35 or less (Medicare.gov).

Second, ACIP-recommended adult vaccines covered under Part D have $0 cost-sharing, effective January 1, 2023. Examples include Part D-covered shingles, Tdap and RSV vaccines; the Part D deductible does not apply (HHS/ASPE). Some vaccines go through Part B instead. Medicare Part B covers hepatitis B vaccination for eligible people, with no charge if the provider accepts assignment. Check which benefit handled your vaccine.

Third, covered Part D drug cost-sharing has an annual threshold: $2,000 in 2025 and $2,100 in 2026 (CMS). After you reach it, new cost-sharing for covered Part D drugs is zero for the rest of the calendar year. Premiums and Prescription Payment Plan installments for costs already incurred can still be due.

If a covered claim appears to exceed the applicable limit, ask the plan to explain or correct it. A receipt alone may not show whether the issue is coverage, days supplied, the cost-sharing calculation or a payment-plan balance.

Why This Happens

• The pharmacy’s computer system hasn’t been updated. Pharmacy billing systems need to receive updated pricing information from your Part D plan. If the system wasn’t updated to reflect the IRA caps, it may charge you the old, higher amount.
• Your Part D plan didn’t communicate the cap to the pharmacy. Your plan is responsible for telling the pharmacy’s system that the cap applies to your prescription. If the plan failed to send this information, the pharmacy charges you the wrong amount.
• You haven’t been identified as IRA-eligible in your plan’s system. Your plan’s records may not correctly flag you as a Medicare Part D enrollee who qualifies for IRA protections. This can happen after plan changes, late enrollment, or data entry errors.
• The pharmacy applied the wrong quantity or days’ supply. The insulin limit applies to each covered product for a one-month supply. A longer supply has a corresponding longer-period limit; ask the plan to verify the product, quantity, days supplied and applicable 2026 amount.
• You already hit the $2,100 cap but the system didn’t catch up. There can be a delay between when your spending reaches $2,100 and when the plan’s system reflects that. In the meantime, you may be charged for drugs that should now be free.

Should You Appeal?

What To Do Next

1. Gather your pharmacy receipts. Find every receipt that shows what you paid. You need the date, the drug name, the amount charged, and the pharmacy name. If you don’t have paper receipts, your pharmacy can print copies, or you can check your Part D plan’s online portal for claims history.
2. Contact the coverage that processed the charge. Give the drug or vaccine name, fill date, quantity, days supplied and amount paid. For covered Part D insulin, ask your drug plan for the product-specific 2026 limit, which may be below $35 for one month. For a Part D vaccine or post-cap drug charge, ask the drug plan which coverage and cost-sharing rule it applied and request any correction or reimbursement owed. If a hepatitis B vaccine went through Part B, ask the provider or 1-800-MEDICARE to review the Part B charge.
3. If the plan doesn’t resolve it, call 1-800-MEDICARE (1-800-633-4227). Tell the representative that your Part D plan is not honoring the Inflation Reduction Act price caps. Medicare can intervene directly with your plan. TTY users can call 1-877-486-2048.
4. Protect the correct review deadline. If the plan refuses payment or the requested cost-sharing correction, request a written coverage determination and follow its appeal instructions, generally within 65 days of the denial notice date. For poor customer service or handling delays, a separate grievance generally is due within 60 days of the incident. Do not wait 30 days or rely on a complaint to preserve a payment appeal.
5. Ask about the Medicare Prescription Payment Plan. If your drug costs are high early in the year, ask your plan to enroll you in the Medicare Prescription Payment Plan. This lets you spread your annual out-of-pocket costs into smaller monthly payments instead of paying large amounts at the pharmacy counter. All Part D plans must offer this option.
6. Contact your SHIP for free help. Your State Health Insurance Assistance Program provides free, unbiased counseling to people with Medicare. A SHIP counselor can help you request a refund, file a complaint, or review your drug costs. Find your local SHIP at shiphelp.org or call 1-800-MEDICARE.

Sources

• CMS: Inflation Reduction Act and Medicare — landing page covering the IRA’s drug-price provisions, including the insulin cap, vaccine cost-sharing elimination, and the Part D out-of-pocket cap.
• CMS: Final CY 2026 Part D Redesign Program Instructions — primary source for the 2026 Part D out-of-pocket cap of $2,100 (the 2025 cap of $2,000 indexed for inflation) and the $615 maximum plan deductible.
• CMS: CY 2026 Actuarial Bid Questions and HHS/ASPE: The Changing Insulin Affordability Landscape — the 2026 lesser-of insulin cost-sharing formula.
• Medicare.gov: Insulin — covered insulin and the separate Part B pump rules.
• HHS/ASPE: Medicare Part D Enrollee Vaccine Use After Elimination of Cost Sharing for Recommended Vaccines in 2023 and CMS: 2026 Medicare Advantage and Part D Rate Announcement — $0 cost-sharing for ACIP-recommended adult vaccines covered under Part D.
• Medicare.gov: Hepatitis B vaccines — Part B coverage and cost-sharing for eligible beneficiaries.
• Medicare.gov: How much does Medicare drug coverage cost? — beneficiary-facing summary of the post-2025 Part D benefit phases (deductible, initial coverage, catastrophic).
• CMS: Medicare Prescription Payment Plan — official page for the spread-payment option, available in every Part D and MA-PD plan starting January 1, 2025.
• 42 CFR 423.566: Coverage determinations and Medicare.gov: Drug-plan appeals — payment and cost-sharing disputes.
• CMS: Part D grievances — the separate service-complaint procedure and standard filing deadline.

Frequently Asked Questions